Catalog No.
RHD62301
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Monoclonal
Tested applications
IF: 1:50-1:200, WB: 1:1000-1:2000
Target
REP-1, REP1, Choroideremia protein, Rab escort protein 1, TCD, CHM, Rab proteins geranylgeranyltransferase component A 1, TCD protein
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P24386
Applications
IF, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.
Clone ID
R1S57
Cost-effectiveness analysis of first-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma., PMID:40433373
Pharmacokinetic Characterization of Cendakimab Administered with Different Devices and at Different Injection Sites in Healthy Participants., PMID:40374841
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial., PMID:40097657
Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine., PMID:39905416
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies., PMID:39898019
Total syntheses of cyclohelminthol I-IV reveal a new cysteine-selective covalent reactive group., PMID:39886435
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study., PMID:39786390
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial., PMID:39662486
An ingenious electrochemical system based on naphthalenediimide derivatives for ultrasensitive immunosensing of alpha-fetoprotein., PMID:39488157
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma., PMID:39476124
Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma., PMID:39266543
Protein-driven interaction enhanced electrochemiluminescence biosensor of hydrogen-bonded biohybrid organic frameworks for sensitive immunoassay of disease markers., PMID:39226752
Blunting specific T-dependent antibody responses with engineered "decoy" B cells., PMID:39192583
Dual-responsive electrochemical immunosensor for CYFRA21-1 detection based on Au/Co Co-loaded 3D ordered macroporous carbon interconnected framework., PMID:39053032
Au NPs modified Ni-B nanosheets/graphene oxide three-dimensional network as label-free electrochemical immunosensor for the detection of diethylstilbestrol., PMID:39003948
Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism., PMID:38988823
An Open-Label Phase II Study Assessing the Safety of Bilateral, Sequential Administration of Retinal Gene Therapy in Participants with Choroideremia: The GEMINI Study., PMID:38970425
Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion., PMID:38826376
Highly sensitive photoelectrochemical biosensing detection of early cardiac injury enabled by novel self-assembled Bi2O3/MgIn2S4 photoelectrode coupled with ZnSnO3 quencher., PMID:38776780
Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT)., PMID:38674305
FeNi-MIL-88B-based electrochemiluminescence immunosensor for ultra-sensitive detection of CD44 protein via dual-quenching strategy., PMID:38609255
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis., PMID:38502227
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors., PMID:38349570
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP., PMID:38271621
2D Z-scheme ZnIn2S4/g-C3N4 heterojunction based on photoelectrochemical immunosensor with enhanced carrier separation for sensitive detection of CEA., PMID:38147720
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses., PMID:38135686
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells., PMID:37986911
Induction of long-term tolerance to a specific antigen using anti-CD3 lipid nanoparticles following gene therapy., PMID:37920545
Synergetic-effect-enhanced electrochemiluminescence of zein-protected Au-Ag bimetallic nanoclusters for CA15-3 detection., PMID:37709422
Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies., PMID:37698932
Choroideremia presenting as vision loss secondary to choroidal neovascularization., PMID:37575054
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction., PMID:37330528
Cloning, expression and activity analysises of chalcone synthase genes in Carthamus tinctorius., PMID:37265765
Immunohistochemical expression of BCL-2 in hydatidiform moles: a tissue microarray study., PMID:37216303
Nivolumab for locally advanced and metastatic cutaneous squamous cell carcinoma (NIVOSQUACS study)-Phase II data covering impact of concomitant haematological malignancies., PMID:37210651
ReS2@Au NPs as signal labels quenching steady photocurrent generated by NiCo2O4/CdIn2S4/In2S3 heterojunction for sensitive detection of CYFRA 21-1., PMID:36495720
PB@PDA nanocomposites as nanolabels and signal reporters for separate-type cathodic photoelectrochemical immunosensors in the detection of carcinoembryonic antigens., PMID:36450179
CoNi-RGO and NiCo2S4-ZIF/g-C3N4 signal amplified electrochemical immunosensors for sensitive detection of CYFRA 21-1., PMID:36243134
Recognition of Aβ oligomer by LilrB2 acceptor: a tetracoordinated zipper mechanism., PMID:36125588
Differences in clinical characteristics among 726 patients with Chinese herbal medicine- or Western medicine-induced liver injury., PMID:35960048
Pharmacokinetics and pharmacodynamics of pozelimab alone or in combination with cemdisiran in non-human primates., PMID:35709087
Rapid and Sensitive Detection of Antigen from SARS-CoV-2 Variants of Concern by a Multivalent Minibinder-Functionalized Nanomechanical Sensor., PMID:35652578
Real-World Effects of Chinese Herbal Medicine for Idiopathic Membranous Nephropathy (REACH-MN): Protocol of a Registry-Based Cohort Study., PMID:35046805
A glycan-based plasmonic sensor for prostate cancer diagnosis., PMID:34623365
Characterization of New Allergens from the Venom of the European Paper Wasp Polistes dominula., PMID:34437431
OVA-Experienced CD4+ T Cell Transfer and Chicken Protein Challenge Affect the Immune Response to OVA in a Murine Model., PMID:34207474
COVID-19 among Minority Children in Detroit, Michigan during the Early National Surge of the Pandemic., PMID:34104706
Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes., PMID:34018382
Liposome encapsulated electron donor strategy for signal-on CYFRA 21-1 photoelectrochemical analysis., PMID:33558974
[Persistent gestational trophoblastic disease following ectopic molar pregnancy]., PMID:33512127
For research use only. Not for human or drug use.
